Dabur

Dabur India Ltd (derived from Daktar Burman) is an Indian multinational consumer goods company, founded in 1884 by S. K. Burman and headquartered in Ghaziabad, Uttar Pradesh. It manufactures Ayurvedic medicine and natural consumer products. It is one of the largest fast-moving consumer goods (FMCG) companies in India.
History.
In the mid-1880s, Dr. S.K. Burman, an Ayurvedic practitioner in Kolkata, formulated Ayurvedic medicines for diseases like cholera, constipation and malaria. He went on to set up Dabur India Ltd in 1884 to mass-produce his Ayurvedic formulations. His son, C.L. Burman, set up Dabur's first R&D unit. The current chairman, Dr. Anand Burman, and vice-chairman Amit Burman, are part of the fifth generation of the family. They were among the first business families in India to separate ownership from management, when they handed over the management of the company to professionals in 1998.
Pharma and healthcare.
Dabur demerged its Pharma business in 2003 and hived it off into a separate company, Dabur Pharma Ltd. German company Fresenius SE bought a 73.27% equity share in Dabur Pharma in June 2008 at ₹76.50 a share.
Dabur International, a fully owned subsidiary of Dabur India formerly held shares in the UAE-based Weikfield International, which it sold in June 2012.
Philanthropy.
Dabur's Sustainable Development Society (Sundesh), is a non-profit organisation started by Burman that aims to carry out welfare activities in the spheres of health care, education and other socio-economic activities. Dabur drives its corporate social responsibility (CSR) initiatives through Sundesh.
The 2015 Brand Trust Report puts Dabur at 19th place.
Controversy.
Former executive director Pradip Burman was on the list of black money account holders on 27 October 2014 when BJP government revealed the names. Dabur rejected the black money charge.
In December 2020, a report by the Centre for Science and Environment showed that Dabur Honey, along with other major brands' products, was adulterated with sugar syrup.